PAM
PAND

Panagora Asset Management’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Panagora Asset Management’s Portfolio PAND Stock Details PAND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,959
Closed -$118K – 3173
2021
Q1 		$118K Buy
+1,959
New +$70.9K ﹤0.01% 1922

Panagora Asset Management's PAND Position: Q2 2021 in Review

Panagora Asset Management sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 1,959 shares — an estimated $118K sold.

Panagora Asset Management first reported a position in PAND in Q1 2021 and held it in 1 quarter. The position peaked at $118K in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

  • Panagora Asset Management reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Panagora Asset Management sold 1,959 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $118K.
  • Panagora Asset Management first reported a position in Pandion Therapeutics Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Panagora Asset Management's Pandion Therapeutics Inc. Common Stock position peaked at $118K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Panagora Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.